Lumigen, Inc.

Southfield, MI 48034

SBIR Award Summary

Total Number of Awards 12
Total Value of Awards $1.77MM
First Award Date 03/01/94
Most Recent Award Date 09/01/07

Key Personnel

Last Name Name Awards Contact
Akhavan-Tafti Hashem Akhavan-Tafti 12

12 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-06
Budget: 09/01/07 - 08/31/08

DESCRIPTION (provided by applicant): This Phase II project continues the development and application of new materials, especially magnetic microparticles for directly isolating DNA from cells, tissues, and biological fluids, including whole blood, in an extremely rapid format. The materials eliminate the need to perform a lysis step and capture ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-06
Budget: 09/01/06 - 08/31/07

DESCRIPTION (provided by applicant): This Phase II project continues the development and application of new materials, especially magnetic microparticles for directly isolating DNA from cells, tissues, and biological fluids, including whole blood, in an extremely rapid format. The materials eliminate the need to perform a lysis step and capture ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/05 - 01/31/06

DESCRIPTION (provided by applicant): The objective of the proposed study is to develop new materials for the rapid isolation of nucleic acids from complex matrices such as whole blood. In Phase I we will prepare functionalized \microparticles for binding and releasing nucleic acids that utilize proprietary chemistry recently i developed at Lu...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/04 - 07/31/05

DESCRIPTION (provided by applicant): Phase I of this proposal proved the feasibility of detection of the factor V Leiden mutation in human blood and correct determination of sample genotype as compared to a reference PCR method. The protocol used a new nucleic acid ligation-based technology, LMO amplification, invented at Lumigen. The LMO techno...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/03 - 07/31/04

DESCRIPTION (provided by applicant): Phase I of this proposal proved the feasibility of detection of the factor V Leiden mutation in human blood and correct determination of sample genotype as compared to a reference PCR method. The protocol used a new nucleic acid ligation-based technology, LMO amplification, invented at Lumigen. The LMO techno...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/02 - 09/30/02

The objective of Phase I is to prepare a new family of chemiluminescent label compounds which can be conjugated to proteins and nucleic acids, subjected to electrophoresis and triggered to generate chemiluminescence in the gel. Successful development of the labeling compounds will permit the development of simple methods for direct detection in ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/01 - 10/31/01

DESCRIPTION (Applicant's Abstract): The objective of Phase 1 is to develop a sensitive test and kit for detection of the Factor V Leiden mutation in human blood using a new nucleic acid ligation-based technology invented at Lumigen. The ligation technology is based on the discovery that a multitude of short oligonu...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/98 - 10/31/98

DESCRIPTION (Adapted from investigator's abstract): This project proposes to demonstrate the feasibility of a novel multiplexed chemiluminescent system for manual DNA sequencing or detection of double-stranded DNA that can potentially replace the use of radioprobes in small scale sequenci...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/97 - 06/30/98

The objective of Phase I is to develop simple, sensitive and unambiguous chemiluminescent detection of juxtaposed genes in chromosomal translocations associated with many cancers. We propose chemiluminescent assay formats based on simultaneous probing and detection of both genes of a translocation in a si...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/17/96 - 06/30/98

Load More